Sevoflurane

BAXTER HEALTHCARE CORPORATION

Revision date : 2026-05-19

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

28523-86-6

Name of the chemical

Sevoflurane

Concentration

N/A

Listed in

General Information

Revision date

2026-05-19

Product name

Sevoflurane

Substance name

Pure substance/mixture

Product Synonyms

ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl-, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane, MR6S4, propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-, Sevofrane, Travenol, Sevorane, general inhalation volatile anaesthetic halogenated ether

CAS No.

28523-86-6

1.2.1 Relevant identified uses

Anesthetic

Emergency telephone

+1 760 476 3962

Icons in SDS

GHS07 GHS08 M004 M009 M010 M011 M013 M059

Company Information

company name

BAXTER HEALTHCARE CORPORATION

GHS Information

Signal word

Warning

Hazard Codes

Hazard statements (CLP)

H315, H319, H336, H361

Hazard statements

Code

Statements

H315

Causes skin irritation

Section 2

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to

Contains

Sevoflurane 0 % of components with unknown hazards to the aquatic environment

Signal word

Warning

Hazard statements

H315 - Causes skin irritation H319 - Causes serious eye irritation H336 - May cause drowsiness or dizziness H361 - Suspected of damaging fertility or the unborn child

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing dust, fume, gas, mist, vapors and spray. P264 - Wash face, hands and any exposed skin thoroughly after handling. P280 - Wear protective gloves, protective clothing, eye protection and face protection. P321 - Specific treatment (see .? on this label). P501 - Dispose of contents and container in accordance with local, regional, national, and international regulations as applicable. Unknown acute toxicity 0 % of the mixture consists of ingredient(s) of unknown acute oral toxicity. 100 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 100 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas). 100 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor). 100 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). Unknown aquatic toxicity

Additional information

This product requires tactile warnings if supplied to the general public.

2.3 Other hazards

No information available. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 2 - (H319) Reproductive toxicity Category 2 - (H361) Specific target organ toxicity (single exposure) Category 3 - (H336) Category 3 Narcotic effects

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.